Grants per year
Grants
- 2 Active
Search results
-
Active
Prot #VRDN-001-301: A Randomized, Double-Masked, Placebo-Controlled Safety, Tolerability, and Efficacy Study of VRDN-001, a Humanized Monoclonal Antibody Directed Against the IGF-1 Receptor, in Participants with Chronic Thyroid Eye Disease (TED)
Cohen, L. M. (PD/PI)
Parexel, miRagen Therapeutics, Inc.
4/2/24 → 4/2/27
Project: Research project